MENU
+Compare
RENXF
Stock ticker: OTC
AS OF
Nov 13 closing price
Price
$0.08
Change
-$0.00 (-0.00%)
Capitalization
39.3M

RENXF Renalytix plc Forecast, Technical & Fundamental Analysis

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally... Show more

RENXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RENXF with price predictions
Nov 12, 2025

RENXF's RSI Oscillator is remaining in oversold zone for 20 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on October 29, 2025. You may want to consider a long position or call options on RENXF as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RENXF just turned positive on November 06, 2025. Looking at past instances where RENXF's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

RENXF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

RENXF moved below its 50-day moving average on October 15, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RENXF crossed bearishly below the 50-day moving average on October 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for RENXF entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (20.827). P/E Ratio (0.000) is within average values for comparable stocks, (113.023). RENXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.450). RENXF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (7.087) is also within normal values, averaging (68.870).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RENXF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RENXF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

View a ticker or compare two or three
RENXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDCVF78.096.84
+9.60%
Sa des Ciments Vicat
MTTRF7.340.10
+1.45%
Mattr Corp.
AGTX0.04N/A
+0.72%
Agentix Corp.
VMTG0.02N/A
N/A
Victor Mining Industry Group Inc.
LFCBY18.40N/A
N/A
Lifco AB

Groups containing RENXF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENXF
1D Price
Change %
RENXF100%
N/A
Health Services
category (422 stocks)
-0%
Poorly correlated
-2.10%
Services to the Health Industry
category (91 stocks)
-0%
Poorly correlated
-2.10%